Carbamazepine as an anticonvulsant: a pilot study.
D000284:Administration, Oral; D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use*; D002220:Carbamazepine / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D003875:Drug Eruptions / Q000209:etiology; D004827:Epilepsy / Q000188:drug therapy*; D005133:Eye Movements; D006801:Humans; D009069:Movement Disorders / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D010672:Phenytoin / Q000627:therapeutic use; D013997:Time Factors; D014474:Unconsciousness / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D000927:Anticonvulsants; D002220:Carbamazepine; D010672:Phenytoin